Pediatric Thyroidectomy: Surgical Extension Does Not Affect Survival
Topic overview
National database analysis of 326 matched pediatric patients with early-stage papillary thyroid cancer found no survival difference between total thyroidectomy and lobectomy over median 5-8 year follow-up. Findings challenge current aggressive treatment guidelines and suggest lobectomy may be sufficient for low-risk cases, avoiding lifelong hormone replacement.
Key takeaways
- Total thyroidectomy does not improve survival vs lobectomy in children with early-stage PTC <4cm (median 5-8yr follow-up, p>0.3)
- Current guidelines recommending total thyroidectomy + radioablation for most pediatric PTC may be unnecessarily aggressive for localized disease
- Thyroid lobectomy may be adequate for low-risk pediatric PTC, avoiding lifelong thyroid hormone replacement without compromising outcomes
- Propensity-matched analysis of 326 pediatric patients showed no difference in overall or disease-specific survival between surgical approaches
- Consider less aggressive surgical management for children with localized PTC to reduce treatment burden while maintaining oncologic safety
Comments